Clinical Trial Update: A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

View source ↗

Summary

An ongoing long-term safety follow-up study in paediatric participants with growth hormone deficiency treated with somapacitan to monitor safety and clinical pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Neoplasms

Drugs mentioned

• Somapacitan (somapacitan)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Deficiency, Neoplasms | Status: ENROLLING_BY_INVITATION